nodes	percent_of_prediction	percent_of_DWPC	metapath
Repaglinide—ALB—Fluorouracil—head and neck cancer	0.241	0.434	CbGbCtD
Repaglinide—CYP2C8—Fluorouracil—head and neck cancer	0.186	0.336	CbGbCtD
Repaglinide—CYP3A4—Vinblastine—head and neck cancer	0.0699	0.126	CbGbCtD
Repaglinide—CYP3A4—Docetaxel—head and neck cancer	0.0576	0.104	CbGbCtD
Repaglinide—Ischaemia—Vinblastine—head and neck cancer	0.0246	0.086	CcSEcCtD
Repaglinide—PPARG—Transcription factor regulation in adipogenesis—CEBPA—head and neck cancer	0.01	0.0626	CbGpPWpGaD
Repaglinide—PPARG—Differentiation of white and brown adipocyte   —CEBPA—head and neck cancer	0.00903	0.0565	CbGpPWpGaD
Repaglinide—Hepatic enzyme increased—Hydroxyurea—head and neck cancer	0.00865	0.0302	CcSEcCtD
Repaglinide—ABCC8—FOXA2 and FOXA3 transcription factor networks—CEBPA—head and neck cancer	0.00802	0.0502	CbGpPWpGaD
Repaglinide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—CEBPA—head and neck cancer	0.00778	0.0487	CbGpPWpGaD
Repaglinide—Myocardial ischaemia—Fluorouracil—head and neck cancer	0.00733	0.0256	CcSEcCtD
Repaglinide—PPARG—RXR and RAR heterodimerization with other nuclear receptor—RARB—head and neck cancer	0.00681	0.0426	CbGpPWpGaD
Repaglinide—PPARG—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.00549	0.0344	CbGpPWpGaD
Repaglinide—Angina pectoris—Vinblastine—head and neck cancer	0.00548	0.0192	CcSEcCtD
Repaglinide—Myocardial ischaemia—Docetaxel—head and neck cancer	0.00529	0.0185	CcSEcCtD
Repaglinide—Pancreatitis—Hydroxyurea—head and neck cancer	0.00503	0.0176	CcSEcCtD
Repaglinide—PPARG—Nuclear Receptors—RARB—head and neck cancer	0.00503	0.0314	CbGpPWpGaD
Repaglinide—Acute coronary syndrome—Vinblastine—head and neck cancer	0.00495	0.0173	CcSEcCtD
Repaglinide—Myocardial infarction—Vinblastine—head and neck cancer	0.00492	0.0172	CcSEcCtD
Repaglinide—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.00433	0.0151	CcSEcCtD
Repaglinide—PPARG—Regulation of retinoblastoma protein—CEBPA—head and neck cancer	0.00415	0.026	CbGpPWpGaD
Repaglinide—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—head and neck cancer	0.00405	0.0253	CbGpPWpGaD
Repaglinide—Alopecia—Vinblastine—head and neck cancer	0.00398	0.0139	CcSEcCtD
Repaglinide—PPARG—Nuclear Receptor transcription pathway—RARB—head and neck cancer	0.00397	0.0249	CbGpPWpGaD
Repaglinide—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—head and neck cancer	0.00368	0.0231	CbGpPWpGaD
Repaglinide—PPARG—Transcriptional regulation of white adipocyte differentiation—CEBPA—head and neck cancer	0.00367	0.023	CbGpPWpGaD
Repaglinide—Alopecia—Hydroxyurea—head and neck cancer	0.00363	0.0127	CcSEcCtD
Repaglinide—Angina pectoris—Fluorouracil—head and neck cancer	0.0036	0.0126	CcSEcCtD
Repaglinide—Erythema—Hydroxyurea—head and neck cancer	0.00358	0.0125	CcSEcCtD
Repaglinide—Leukopenia—Vinblastine—head and neck cancer	0.00351	0.0123	CcSEcCtD
Repaglinide—Cardiac failure congestive—Docetaxel—head and neck cancer	0.0034	0.0119	CcSEcCtD
Repaglinide—Hypertension—Vinblastine—head and neck cancer	0.00339	0.0118	CcSEcCtD
Repaglinide—Visual disturbance—Docetaxel—head and neck cancer	0.00326	0.0114	CcSEcCtD
Repaglinide—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.00325	0.0114	CcSEcCtD
Repaglinide—Myocardial infarction—Fluorouracil—head and neck cancer	0.00323	0.0113	CcSEcCtD
Repaglinide—Urinary tract infection—Fluorouracil—head and neck cancer	0.0032	0.0112	CcSEcCtD
Repaglinide—Leukopenia—Hydroxyurea—head and neck cancer	0.0032	0.0112	CcSEcCtD
Repaglinide—Thrombocytopenia—Vinblastine—head and neck cancer	0.00313	0.011	CcSEcCtD
Repaglinide—Sinusitis—Fluorouracil—head and neck cancer	0.00309	0.0108	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00302	0.0106	CcSEcCtD
Repaglinide—Rhinitis—Fluorouracil—head and neck cancer	0.00296	0.0104	CcSEcCtD
Repaglinide—Oedema—Hydroxyurea—head and neck cancer	0.00292	0.0102	CcSEcCtD
Repaglinide—Paraesthesia—Vinblastine—head and neck cancer	0.00287	0.0101	CcSEcCtD
Repaglinide—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00286	0.00999	CcSEcCtD
Repaglinide—Skin disorder—Hydroxyurea—head and neck cancer	0.00284	0.00991	CcSEcCtD
Repaglinide—Constipation—Vinblastine—head and neck cancer	0.00274	0.00957	CcSEcCtD
Repaglinide—Arrhythmia—Fluorouracil—head and neck cancer	0.00264	0.00924	CcSEcCtD
Repaglinide—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00262	0.00915	CcSEcCtD
Repaglinide—Alopecia—Fluorouracil—head and neck cancer	0.00261	0.00914	CcSEcCtD
Repaglinide—Angina pectoris—Docetaxel—head and neck cancer	0.0026	0.00908	CcSEcCtD
Repaglinide—ALB—FOXA2 and FOXA3 transcription factor networks—CEBPA—head and neck cancer	0.00259	0.0162	CbGpPWpGaD
Repaglinide—Erythema—Fluorouracil—head and neck cancer	0.00257	0.009	CcSEcCtD
Repaglinide—Dyspepsia—Hydroxyurea—head and neck cancer	0.00257	0.00898	CcSEcCtD
Repaglinide—CYP3A4—Aflatoxin B1 metabolism—GSTM1—head and neck cancer	0.00255	0.016	CbGpPWpGaD
Repaglinide—Abdominal pain—Vinblastine—head and neck cancer	0.00253	0.00885	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00252	0.00881	CcSEcCtD
Repaglinide—Constipation—Hydroxyurea—head and neck cancer	0.0025	0.00873	CcSEcCtD
Repaglinide—PPARG—Adipogenesis—CEBPA—head and neck cancer	0.00242	0.0151	CbGpPWpGaD
Repaglinide—Hypersensitivity—Vinblastine—head and neck cancer	0.00236	0.00825	CcSEcCtD
Repaglinide—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.00236	0.00824	CcSEcCtD
Repaglinide—Acute coronary syndrome—Docetaxel—head and neck cancer	0.00234	0.0082	CcSEcCtD
Repaglinide—Myocardial infarction—Docetaxel—head and neck cancer	0.00233	0.00815	CcSEcCtD
Repaglinide—Jaundice—Docetaxel—head and neck cancer	0.00232	0.0081	CcSEcCtD
Repaglinide—Leukopenia—Fluorouracil—head and neck cancer	0.0023	0.00806	CcSEcCtD
Repaglinide—KCNJ11—Type II diabetes mellitus—MAPK1—head and neck cancer	0.00227	0.0142	CbGpPWpGaD
Repaglinide—Hepatobiliary disease—Docetaxel—head and neck cancer	0.00225	0.00786	CcSEcCtD
Repaglinide—Chest pain—Fluorouracil—head and neck cancer	0.00219	0.00766	CcSEcCtD
Repaglinide—Diarrhoea—Vinblastine—head and neck cancer	0.00219	0.00766	CcSEcCtD
Repaglinide—PPARG—RXR and RAR heterodimerization with other nuclear receptor—BCL2—head and neck cancer	0.00218	0.0137	CbGpPWpGaD
Repaglinide—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00215	0.00752	CcSEcCtD
Repaglinide—Rhinitis—Docetaxel—head and neck cancer	0.00214	0.00748	CcSEcCtD
Repaglinide—Hepatitis—Docetaxel—head and neck cancer	0.00213	0.00746	CcSEcCtD
Repaglinide—Oedema peripheral—Docetaxel—head and neck cancer	0.0021	0.00735	CcSEcCtD
Repaglinide—Oedema—Fluorouracil—head and neck cancer	0.0021	0.00735	CcSEcCtD
Repaglinide—Anaphylactic shock—Fluorouracil—head and neck cancer	0.0021	0.00735	CcSEcCtD
Repaglinide—Thrombocytopenia—Fluorouracil—head and neck cancer	0.00206	0.00719	CcSEcCtD
Repaglinide—Visual impairment—Docetaxel—head and neck cancer	0.00206	0.00719	CcSEcCtD
Repaglinide—Vomiting—Vinblastine—head and neck cancer	0.00203	0.00712	CcSEcCtD
Repaglinide—Erythema multiforme—Docetaxel—head and neck cancer	0.00202	0.00706	CcSEcCtD
Repaglinide—Headache—Vinblastine—head and neck cancer	0.00201	0.00701	CcSEcCtD
Repaglinide—Diarrhoea—Hydroxyurea—head and neck cancer	0.002	0.00698	CcSEcCtD
Repaglinide—Eye disorder—Docetaxel—head and neck cancer	0.00199	0.00698	CcSEcCtD
Repaglinide—Cardiac disorder—Docetaxel—head and neck cancer	0.00198	0.00693	CcSEcCtD
Repaglinide—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—head and neck cancer	0.00198	0.0124	CbGpPWpGaD
Repaglinide—PPARG—PPARA activates gene expression—YAP1—head and neck cancer	0.00195	0.0122	CbGpPWpGaD
Repaglinide—CYP2C8—Xenobiotics—CYP1A1—head and neck cancer	0.00195	0.0122	CbGpPWpGaD
Repaglinide—PPARG—Adipogenesis—STAT6—head and neck cancer	0.00193	0.0121	CbGpPWpGaD
Repaglinide—Immune system disorder—Docetaxel—head and neck cancer	0.00193	0.00674	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00191	0.00669	CcSEcCtD
Repaglinide—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—YAP1—head and neck cancer	0.00191	0.012	CbGpPWpGaD
Repaglinide—Arrhythmia—Docetaxel—head and neck cancer	0.00191	0.00667	CcSEcCtD
Repaglinide—Nausea—Vinblastine—head and neck cancer	0.0019	0.00665	CcSEcCtD
Repaglinide—Paraesthesia—Fluorouracil—head and neck cancer	0.00189	0.0066	CcSEcCtD
Repaglinide—Alopecia—Docetaxel—head and neck cancer	0.00189	0.0066	CcSEcCtD
Repaglinide—CYP2C8—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.00187	0.0117	CbGpPWpGaD
Repaglinide—Erythema—Docetaxel—head and neck cancer	0.00186	0.0065	CcSEcCtD
Repaglinide—Malnutrition—Docetaxel—head and neck cancer	0.00186	0.0065	CcSEcCtD
Repaglinide—Vomiting—Hydroxyurea—head and neck cancer	0.00186	0.00649	CcSEcCtD
Repaglinide—Dyspepsia—Fluorouracil—head and neck cancer	0.00185	0.00647	CcSEcCtD
Repaglinide—Rash—Hydroxyurea—head and neck cancer	0.00184	0.00644	CcSEcCtD
Repaglinide—Dermatitis—Hydroxyurea—head and neck cancer	0.00184	0.00643	CcSEcCtD
Repaglinide—Headache—Hydroxyurea—head and neck cancer	0.00183	0.00639	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00181	0.00634	CcSEcCtD
Repaglinide—Back pain—Docetaxel—head and neck cancer	0.0018	0.00628	CcSEcCtD
Repaglinide—Nausea—Hydroxyurea—head and neck cancer	0.00173	0.00606	CcSEcCtD
Repaglinide—Urticaria—Fluorouracil—head and neck cancer	0.00167	0.00584	CcSEcCtD
Repaglinide—Leukopenia—Docetaxel—head and neck cancer	0.00166	0.00582	CcSEcCtD
Repaglinide—Palpitations—Docetaxel—head and neck cancer	0.00164	0.00574	CcSEcCtD
Repaglinide—Hypertension—Docetaxel—head and neck cancer	0.0016	0.00561	CcSEcCtD
Repaglinide—Arthralgia—Docetaxel—head and neck cancer	0.00158	0.00553	CcSEcCtD
Repaglinide—Chest pain—Docetaxel—head and neck cancer	0.00158	0.00553	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.00157	0.00549	CcSEcCtD
Repaglinide—Hypersensitivity—Fluorouracil—head and neck cancer	0.00155	0.00541	CcSEcCtD
Repaglinide—Oedema—Docetaxel—head and neck cancer	0.00152	0.0053	CcSEcCtD
Repaglinide—Anaphylactic shock—Docetaxel—head and neck cancer	0.00152	0.0053	CcSEcCtD
Repaglinide—Pruritus—Fluorouracil—head and neck cancer	0.00149	0.0052	CcSEcCtD
Repaglinide—Thrombocytopenia—Docetaxel—head and neck cancer	0.00148	0.00519	CcSEcCtD
Repaglinide—Skin disorder—Docetaxel—head and neck cancer	0.00147	0.00515	CcSEcCtD
Repaglinide—Diarrhoea—Fluorouracil—head and neck cancer	0.00144	0.00503	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.00138	0.00483	CcSEcCtD
Repaglinide—Paraesthesia—Docetaxel—head and neck cancer	0.00136	0.00476	CcSEcCtD
Repaglinide—Vomiting—Fluorouracil—head and neck cancer	0.00134	0.00467	CcSEcCtD
Repaglinide—Dyspepsia—Docetaxel—head and neck cancer	0.00133	0.00467	CcSEcCtD
Repaglinide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.00133	0.00835	CbGpPWpGaD
Repaglinide—Rash—Fluorouracil—head and neck cancer	0.00132	0.00463	CcSEcCtD
Repaglinide—Dermatitis—Fluorouracil—head and neck cancer	0.00132	0.00463	CcSEcCtD
Repaglinide—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—YAP1—head and neck cancer	0.00132	0.00824	CbGpPWpGaD
Repaglinide—Headache—Fluorouracil—head and neck cancer	0.00132	0.0046	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00131	0.00458	CcSEcCtD
Repaglinide—Constipation—Docetaxel—head and neck cancer	0.0013	0.00453	CcSEcCtD
Repaglinide—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.00125	0.00781	CbGpPWpGaD
Repaglinide—Nausea—Fluorouracil—head and neck cancer	0.00125	0.00436	CcSEcCtD
Repaglinide—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00124	0.00434	CcSEcCtD
Repaglinide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—head and neck cancer	0.00123	0.00769	CbGpPWpGaD
Repaglinide—Abdominal pain—Docetaxel—head and neck cancer	0.0012	0.00419	CcSEcCtD
Repaglinide—CYP3A4—Estrogen metabolism—GSTM1—head and neck cancer	0.0012	0.0075	CbGpPWpGaD
Repaglinide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—head and neck cancer	0.00114	0.00712	CbGpPWpGaD
Repaglinide—CYP3A4—Estrogen metabolism—CYP1A1—head and neck cancer	0.00114	0.00711	CbGpPWpGaD
Repaglinide—Hypersensitivity—Docetaxel—head and neck cancer	0.00112	0.00391	CcSEcCtD
Repaglinide—PPARG—PPARA activates gene expression—CYP1A1—head and neck cancer	0.0011	0.00688	CbGpPWpGaD
Repaglinide—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CYP1A1—head and neck cancer	0.00108	0.00673	CbGpPWpGaD
Repaglinide—PPARG—Wnt Signaling Pathway Netpath—CCND1—head and neck cancer	0.00108	0.00673	CbGpPWpGaD
Repaglinide—Pruritus—Docetaxel—head and neck cancer	0.00107	0.00375	CcSEcCtD
Repaglinide—ABCC8—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.00106	0.00662	CbGpPWpGaD
Repaglinide—CYP3A4—Xenobiotics—CYP1A1—head and neck cancer	0.00104	0.00653	CbGpPWpGaD
Repaglinide—Diarrhoea—Docetaxel—head and neck cancer	0.00104	0.00363	CcSEcCtD
Repaglinide—CYP3A4—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.001	0.00628	CbGpPWpGaD
Repaglinide—ALB—Vitamin B12 Metabolism—SOD2—head and neck cancer	0.000968	0.00606	CbGpPWpGaD
Repaglinide—Vomiting—Docetaxel—head and neck cancer	0.000964	0.00337	CcSEcCtD
Repaglinide—Rash—Docetaxel—head and neck cancer	0.000956	0.00334	CcSEcCtD
Repaglinide—Dermatitis—Docetaxel—head and neck cancer	0.000955	0.00334	CcSEcCtD
Repaglinide—ABCC8—FOXA2 and FOXA3 transcription factor networks—AKT1—head and neck cancer	0.000954	0.00597	CbGpPWpGaD
Repaglinide—Headache—Docetaxel—head and neck cancer	0.00095	0.00332	CcSEcCtD
Repaglinide—CYP2C8—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000944	0.00591	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—UROD—head and neck cancer	0.000943	0.0059	CbGpPWpGaD
Repaglinide—CYP2C8—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000935	0.00585	CbGpPWpGaD
Repaglinide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—AKT1—head and neck cancer	0.000925	0.00579	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—UROD—head and neck cancer	0.000915	0.00573	CbGpPWpGaD
Repaglinide—Nausea—Docetaxel—head and neck cancer	0.000901	0.00315	CcSEcCtD
Repaglinide—PPARG—Regulation of retinoblastoma protein—CCND1—head and neck cancer	0.000889	0.00556	CbGpPWpGaD
Repaglinide—PPARG—Wnt Signaling Pathway Netpath—MAPK1—head and neck cancer	0.000844	0.00528	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—CEBPA—head and neck cancer	0.00083	0.0052	CbGpPWpGaD
Repaglinide—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000808	0.00505	CbGpPWpGaD
Repaglinide—CYP2C8—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000797	0.00499	CbGpPWpGaD
Repaglinide—ALB—Folate Metabolism—SOD2—head and neck cancer	0.000788	0.00493	CbGpPWpGaD
Repaglinide—ALB—Folate Metabolism—GPX1—head and neck cancer	0.000752	0.0047	CbGpPWpGaD
Repaglinide—CYP2C8—Biological oxidations—NAT2—head and neck cancer	0.000743	0.00465	CbGpPWpGaD
Repaglinide—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—CYP1A1—head and neck cancer	0.000741	0.00464	CbGpPWpGaD
Repaglinide—CYP2C8—Metapathway biotransformation—NAT2—head and neck cancer	0.000733	0.00458	CbGpPWpGaD
Repaglinide—PPARG—Signaling events mediated by HDAC Class I—STAT3—head and neck cancer	0.000732	0.00458	CbGpPWpGaD
Repaglinide—PPARG—Circadian rythm related genes—TYMS—head and neck cancer	0.000724	0.00453	CbGpPWpGaD
Repaglinide—PPARG—Generic Transcription Pathway—RARB—head and neck cancer	0.000686	0.00429	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—UROD—head and neck cancer	0.000676	0.00423	CbGpPWpGaD
Repaglinide—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000655	0.0041	CbGpPWpGaD
Repaglinide—ALB—Selenium Micronutrient Network—SOD2—head and neck cancer	0.000626	0.00392	CbGpPWpGaD
Repaglinide—PPARG—Generic Transcription Pathway—YAP1—head and neck cancer	0.000624	0.00391	CbGpPWpGaD
Repaglinide—PPARG—Wnt Signaling Pathway Netpath—AKT1—head and neck cancer	0.000598	0.00374	CbGpPWpGaD
Repaglinide—ALB—Selenium Micronutrient Network—GPX1—head and neck cancer	0.000597	0.00374	CbGpPWpGaD
Repaglinide—SLCO1B1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000597	0.00374	CbGpPWpGaD
Repaglinide—PPARG—SREBP signalling—PIK3CA—head and neck cancer	0.000584	0.00365	CbGpPWpGaD
Repaglinide—CYP2C8—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000556	0.00348	CbGpPWpGaD
Repaglinide—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000536	0.00336	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—UROD—head and neck cancer	0.000532	0.00333	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000525	0.00328	CbGpPWpGaD
Repaglinide—PPARG—SREBP signalling—AKT1—head and neck cancer	0.000477	0.00299	CbGpPWpGaD
Repaglinide—PPARG—Adipogenesis—STAT3—head and neck cancer	0.000446	0.00279	CbGpPWpGaD
Repaglinide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000434	0.00271	CbGpPWpGaD
Repaglinide—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000428	0.00268	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000413	0.00258	CbGpPWpGaD
Repaglinide—ALB—Folate Metabolism—IL2—head and neck cancer	0.00041	0.00257	CbGpPWpGaD
Repaglinide—CYP3A4—Biological oxidations—NAT2—head and neck cancer	0.000399	0.0025	CbGpPWpGaD
Repaglinide—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	0.000393	0.00246	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—NAT2—head and neck cancer	0.000392	0.00245	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—NAT2—head and neck cancer	0.00038	0.00238	CbGpPWpGaD
Repaglinide—CYP2C8—Biological oxidations—GSTM1—head and neck cancer	0.000367	0.0023	CbGpPWpGaD
Repaglinide—CYP2C8—Metapathway biotransformation—GSTM1—head and neck cancer	0.000362	0.00226	CbGpPWpGaD
Repaglinide—PPARG—Circadian rythm related genes—PTEN—head and neck cancer	0.000352	0.0022	CbGpPWpGaD
Repaglinide—ALB—Selenium Micronutrient Network—PTGS2—head and neck cancer	0.000352	0.0022	CbGpPWpGaD
Repaglinide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000351	0.0022	CbGpPWpGaD
Repaglinide—CYP2C8—Biological oxidations—CYP1A1—head and neck cancer	0.000348	0.00218	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—DPYD—head and neck cancer	0.000344	0.00215	CbGpPWpGaD
Repaglinide—CYP2C8—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000343	0.00215	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000341	0.00214	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—DPYD—head and neck cancer	0.000333	0.00208	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—RARB—head and neck cancer	0.00033	0.00207	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—YAP1—head and neck cancer	0.000326	0.00204	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—YAP1—head and neck cancer	0.000316	0.00198	CbGpPWpGaD
Repaglinide—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—head and neck cancer	0.000308	0.00193	CbGpPWpGaD
Repaglinide—ABCC8—Neuronal System—MAPK1—head and neck cancer	0.000307	0.00192	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—UROD—head and neck cancer	0.000306	0.00191	CbGpPWpGaD
Repaglinide—ALB—Metabolism—UROD—head and neck cancer	0.000304	0.0019	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—YAP1—head and neck cancer	0.0003	0.00188	CbGpPWpGaD
Repaglinide—ALB—Platelet degranulation—VEGFA—head and neck cancer	0.000299	0.00187	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000298	0.00187	CbGpPWpGaD
Repaglinide—KCNJ11—Neuronal System—MAPK1—head and neck cancer	0.000298	0.00186	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.000295	0.00185	CbGpPWpGaD
Repaglinide—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—head and neck cancer	0.000285	0.00178	CbGpPWpGaD
Repaglinide—PPARG—Generic Transcription Pathway—NOTCH1—head and neck cancer	0.000281	0.00176	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—NAT2—head and neck cancer	0.000281	0.00176	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—NOTCH1—head and neck cancer	0.000265	0.00166	CbGpPWpGaD
Repaglinide—ALB—Folate Metabolism—TP53—head and neck cancer	0.000263	0.00165	CbGpPWpGaD
Repaglinide—ABCC8—Neuronal System—HRAS—head and neck cancer	0.000247	0.00154	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—DPYD—head and neck cancer	0.000246	0.00154	CbGpPWpGaD
Repaglinide—PPARG—Circadian rythm related genes—TP53—head and neck cancer	0.00024	0.0015	CbGpPWpGaD
Repaglinide—KCNJ11—Neuronal System—HRAS—head and neck cancer	0.000239	0.0015	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000237	0.00149	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000236	0.00148	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000235	0.00147	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—YAP1—head and neck cancer	0.000234	0.00146	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.000232	0.00145	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—NAT2—head and neck cancer	0.000221	0.00138	CbGpPWpGaD
Repaglinide—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	0.000197	0.00123	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—TYMS—head and neck cancer	0.000196	0.00122	CbGpPWpGaD
Repaglinide—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	0.000194	0.00122	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—DPYD—head and neck cancer	0.000194	0.00121	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—GSTM1—head and neck cancer	0.000193	0.00121	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—TYMS—head and neck cancer	0.00019	0.00119	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—GSTM1—head and neck cancer	0.000188	0.00117	CbGpPWpGaD
Repaglinide—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	0.000187	0.00117	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—GPX1—head and neck cancer	0.000185	0.00116	CbGpPWpGaD
Repaglinide—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000184	0.00115	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—YAP1—head and neck cancer	0.000184	0.00115	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—CYP1A1—head and neck cancer	0.000183	0.00115	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—GPX1—head and neck cancer	0.00018	0.00112	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—CYP1A1—head and neck cancer	0.000178	0.00111	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	0.000176	0.0011	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—UROD—head and neck cancer	0.000164	0.00103	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—IL2—head and neck cancer	0.000156	0.000976	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—VEGFA—head and neck cancer	0.000155	0.000969	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—STAT3—head and neck cancer	0.000153	0.000959	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	0.000153	0.000958	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—MAPK3—head and neck cancer	0.000146	0.000917	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—TYMS—head and neck cancer	0.00014	0.000878	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—MAPK1—head and neck cancer	0.000139	0.000872	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—EGFR—head and neck cancer	0.000139	0.000872	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—GSTM1—head and neck cancer	0.000139	0.000868	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	0.000138	0.000865	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—NOTCH1—head and neck cancer	0.000135	0.000847	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000135	0.000844	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000134	0.00084	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.000134	0.000836	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.000133	0.000831	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—GPX1—head and neck cancer	0.000133	0.000831	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—VEGFA—head and neck cancer	0.000133	0.00083	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—CYP1A1—head and neck cancer	0.000131	0.000823	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—NAT2—head and neck cancer	0.000127	0.000795	CbGpPWpGaD
Repaglinide—ALB—Metabolism—NAT2—head and neck cancer	0.000126	0.00079	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—MAPK3—head and neck cancer	0.000125	0.000785	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	0.000121	0.000754	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—MAPK1—head and neck cancer	0.000119	0.000747	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—HRAS—head and neck cancer	0.000112	0.0007	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—DPYD—head and neck cancer	0.000111	0.000697	CbGpPWpGaD
Repaglinide—ALB—Metabolism—DPYD—head and neck cancer	0.000111	0.000693	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—TYMS—head and neck cancer	0.00011	0.000691	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—GSTM1—head and neck cancer	0.000109	0.000683	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—PTGS2—head and neck cancer	0.000109	0.000683	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	0.000108	0.000676	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—PTGS2—head and neck cancer	0.000106	0.000662	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—YAP1—head and neck cancer	0.000106	0.000662	CbGpPWpGaD
Repaglinide—ALB—Metabolism—YAP1—head and neck cancer	0.000105	0.000658	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—GPX1—head and neck cancer	0.000105	0.000654	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—PIK3CA—head and neck cancer	0.000104	0.000648	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—CYP1A1—head and neck cancer	0.000104	0.000648	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—AKT1—head and neck cancer	9.88e-05	0.000618	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—PTEN—head and neck cancer	9.51e-05	0.000595	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—PTEN—head and neck cancer	9.22e-05	0.000577	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	8.5e-05	0.000532	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—AKT1—head and neck cancer	8.46e-05	0.000529	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—IL2—head and neck cancer	8.04e-05	0.000503	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	7.94e-05	0.000497	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	7.9e-05	0.000494	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—PTGS2—head and neck cancer	7.82e-05	0.000489	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—MAPK3—head and neck cancer	7.49e-05	0.000469	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	6.93e-05	0.000433	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	6.89e-05	0.000431	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—VEGFA—head and neck cancer	6.83e-05	0.000428	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—NAT2—head and neck cancer	6.82e-05	0.000427	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—PTEN—head and neck cancer	6.82e-05	0.000427	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—PIK3CA—head and neck cancer	6.71e-05	0.00042	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—PIK3CA—head and neck cancer	6.51e-05	0.000407	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—MAPK3—head and neck cancer	6.46e-05	0.000405	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—TYMS—head and neck cancer	6.35e-05	0.000397	CbGpPWpGaD
Repaglinide—ALB—Metabolism—TYMS—head and neck cancer	6.31e-05	0.000395	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—GSTM1—head and neck cancer	6.27e-05	0.000393	CbGpPWpGaD
Repaglinide—ALB—Metabolism—GSTM1—head and neck cancer	6.24e-05	0.00039	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PTGS2—head and neck cancer	6.16e-05	0.000385	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—MAPK1—head and neck cancer	6.15e-05	0.000385	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—GPX1—head and neck cancer	6.01e-05	0.000376	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—DPYD—head and neck cancer	5.98e-05	0.000374	CbGpPWpGaD
Repaglinide—ALB—Metabolism—GPX1—head and neck cancer	5.97e-05	0.000374	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—CYP1A1—head and neck cancer	5.95e-05	0.000372	CbGpPWpGaD
Repaglinide—ALB—Metabolism—CYP1A1—head and neck cancer	5.91e-05	0.00037	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—YAP1—head and neck cancer	5.67e-05	0.000355	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—AKT1—head and neck cancer	5.48e-05	0.000343	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PTEN—head and neck cancer	5.37e-05	0.000336	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—PIK3CA—head and neck cancer	5.34e-05	0.000334	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—AKT1—head and neck cancer	5.32e-05	0.000333	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—TP53—head and neck cancer	5.16e-05	0.000323	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—AKT1—head and neck cancer	5.05e-05	0.000316	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—HRAS—head and neck cancer	4.94e-05	0.000309	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	4.89e-05	0.000306	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	4.86e-05	0.000304	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—PIK3CA—head and neck cancer	4.81e-05	0.000301	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—AKT1—head and neck cancer	4.36e-05	0.000273	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—AKT1—head and neck cancer	3.93e-05	0.000246	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PIK3CA—head and neck cancer	3.79e-05	0.000237	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PTGS2—head and neck cancer	3.54e-05	0.000221	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PTGS2—head and neck cancer	3.52e-05	0.00022	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—TYMS—head and neck cancer	3.41e-05	0.000213	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GSTM1—head and neck cancer	3.37e-05	0.000211	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GPX1—head and neck cancer	3.23e-05	0.000202	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CYP1A1—head and neck cancer	3.19e-05	0.0002	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—AKT1—head and neck cancer	3.09e-05	0.000194	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PTEN—head and neck cancer	3.08e-05	0.000193	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PTEN—head and neck cancer	3.07e-05	0.000192	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PIK3CA—head and neck cancer	2.18e-05	0.000136	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PIK3CA—head and neck cancer	2.16e-05	0.000135	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PTGS2—head and neck cancer	1.9e-05	0.000119	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—AKT1—head and neck cancer	1.78e-05	0.000111	CbGpPWpGaD
Repaglinide—ALB—Metabolism—AKT1—head and neck cancer	1.77e-05	0.000111	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PTEN—head and neck cancer	1.66e-05	0.000104	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PIK3CA—head and neck cancer	1.17e-05	7.31e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—AKT1—head and neck cancer	9.54e-06	5.97e-05	CbGpPWpGaD
